The company will use the proceeds to part-repay its debt, which stands at Rs 34,000 crore (Rs 340 billion) even after the recent qualified institutional placement of its shares. An RCom board committee recently approved the sale of these assets.
Unlike Reliance Jio's focus on 4G, it plans to segment the data market based on device prices and spectrum.
In a letter to health minister Harsh Vardhan, the Indian Pharmaceutical Alliance, an industry body representing leading pharma companies, including Sun Pharma, Lupin, Dr Reddy's Labs, Cadila Health and Glenmark, stressed the need for an out-of-court settlement with health activists fighting for the rights of clinical trial participants.
The Drug (Prices Control) Order implemented in May last year brought into its purview 652 packs of 348 formulations.
The company did not respond to specific queries on the project's expansion.
FDI in the defence sector during 2000-2014 has been a meagre $4.94 billion, despite the total FDI flow into the country across sectors standing at $321.81 billion.
The market could see a fresh round of tariff war, similar to what happened in the voice market a few years ago.
Top companies added employees at 3% CAGR from 2003-04 to 2013-14, while revenues grew at 18%.
Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.
Components manufactured in India are low-value products like casing and box packaging that constitute 5% of the bill for materials required in phone manufacturing.
Experts say despite it being a global deal, the transaction will have to undergo CCI scrutiny because of the scale of operations.
On Tuesday, Novartis agreed to buy GSK's oncology products business for $14.5 billion, while selling its vaccines business, excluding flu, to GSK for $7.1 billion.
ICAI has also imposed a fine of Rs 5 lakh on each of the three accused in Satyam case.
Removal of mark-ups to be paid by Maruti, other changes could raise funding need to Rs 6,000 crore.
The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.
The NPPA letter was issued to GSK on Wednesday.
Apart from Wockhardt, only Biocon manufactures insulin analog indigenously.
What started as a mere payment delay seems to have grown into a tussle between the government and leading private hospitals, empanelled under the Central Government Health Scheme.
Legal experts and official sources said the alleged submission of fake documents can also lead to criminal charges against Novartis.
LIC is one of the largest Indian shareholders in the country's largest car maker, with a 6.93% stake.